These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35969769)

  • 1. Endothelial VWF is critical for the pathogenesis of vaso-occlusive episode in a mouse model of sickle cell disease.
    Shi H; Shao B; Gao L; Venkatesan T; McDaniel JM; Zhou M; McGee S; Yu P; Ahamed J; Journeycake J; George JN; Xia L
    Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207592119. PubMed ID: 35969769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state.
    Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K
    J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance of VWF by hepatic macrophages is critical for the protective effect of ADAMTS13 in sickle cell anemia mice.
    Shi H; Gao L; Kirby N; Shao B; Shan X; Kudo M; Silasi R; McDaniel JM; Zhou M; McGee S; Jing W; Lupu F; Cleuren A; George JN; Xia L
    Blood; 2024 Mar; 143(13):1293-1309. PubMed ID: 38142410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
    Rossato P; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Rottensteiner H; Gritsch H; Federti E; Matte A; De Franceschi L; Scheiflinger F; Hoellriegl W
    J Thromb Haemost; 2023 Feb; 21(2):269-275. PubMed ID: 36700507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of ADAMTS13-independent VWF regulation in sickle cell disease.
    Hunt RC; Katneni U; Yalamanoglu A; Indig FE; Ibla JC; Kimchi-Sarfaty C
    J Thromb Haemost; 2022 Sep; 20(9):2098-2108. PubMed ID: 35753044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
    Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease.
    Rossato P; Federti E; Matte A; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Andolfo I; Iolascon A; Rottensteiner H; Gritsch H; Scheiflinger F; Hoellriegl W; Franceschi L
    Haematologica; 2022 Nov; 107(11):2650-2660. PubMed ID: 35443560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VWF-ADAMTS13 axis dysfunction in children with sickle cell disease treated with hydroxycarbamide vs blood transfusion.
    Fogarty H; Ahmad A; Atiq F; Doherty D; Ward S; Karampini E; Rehill A; Leon G; Byrne C; Geoghegan R; Conroy H; Byrne M; Budde U; Schneppenheim S; Sheehan C; Ngwenya N; Baker RI; Preston RJS; Tuohy E; McMahon C; O'Donnell JS
    Blood Adv; 2023 Nov; 7(22):6974-6989. PubMed ID: 37773926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients.
    Chenou F; Hounkpe BW; Domingos IF; Tonassé WV; Batista THC; Santana RM; Arcanjo GDS; Alagbe AE; Araújo ADS; Lucena-Araújo AR; Bezerra MAC; Costa FF; Sonati MF; De Paula EV; Dos Santos MNN
    Ann Hematol; 2021 Nov; 100(11):2669-2676. PubMed ID: 34453189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma.
    Chen J; Hobbs WE; Le J; Lenting PJ; de Groot PG; López JA
    Blood; 2011 Mar; 117(13):3680-3. PubMed ID: 21300978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAMTS13 activity in sickle cell disease.
    Schnog JJ; Kremer Hovinga JA; Krieg S; Akin S; Lämmle B; Brandjes DP; Mac Gillavry MR; Muskiet FD; Duits AJ;
    Am J Hematol; 2006 Jul; 81(7):492-8. PubMed ID: 16755558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAMTS13 and von Willebrand factor assessment in steady state and acute vaso-occlusive crisis of sickle cell disease.
    Demagny J; Driss A; Stepanian A; Anguel N; Affo L; Roux D; Habibi A; Benghezal S; Capdenat S; Coppo P; Driss F; Veyradier A
    Res Pract Thromb Haemost; 2021 Jan; 5(1):197-203. PubMed ID: 33537544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemoglobin blocks von Willebrand factor proteolysis by ADAMTS-13: a mechanism associated with sickle cell disease.
    Zhou Z; Han H; Cruz MA; López JA; Dong JF; Guchhait P
    Thromb Haemost; 2009 Jun; 101(6):1070-7. PubMed ID: 19492149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of Thrombospondin 1 to von Willebrand Factor and ADAMTS-13 in Sickle Cell Disease Patients of Arab Ethnicity.
    Al-Awadhi A; Adekile A; Marouf R
    Acta Haematol; 2021; 144(2):182-189. PubMed ID: 32987383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular link between intravascular hemolysis and vascular occlusion in sickle cell disease.
    Zhou Z; Yee DL; Guchhait P
    Curr Vasc Pharmacol; 2012 Nov; 10(6):756-61. PubMed ID: 22272904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial Cell-Derived Von Willebrand Factor, But Not Platelet-Derived, Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
    Doddapattar P; Dhanesha N; Chorawala MR; Tinsman C; Jain M; Nayak MK; Staber JM; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):520-528. PubMed ID: 29348121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of endothelial dysfunction differ between subphenotypes in children with sickle cell disease.
    van der Land V; Peters M; Biemond BJ; Heijboer H; Harteveld CL; Fijnvandraat K
    Thromb Res; 2013; 132(6):712-7. PubMed ID: 24182550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of von Willebrand factor and ADAMTS-13 antigen and activity levels in sickle cell disease patients in Kuwait.
    Al-Awadhi A; Adekile A; Marouf R
    J Thromb Thrombolysis; 2017 Jan; 43(1):117-123. PubMed ID: 27613177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The invisible string of coagulation, complement, iron, and inflammation in sickle cell disease.
    Beckman JD; Sparkenbaugh EM
    Curr Opin Hematol; 2023 Sep; 30(5):153-158. PubMed ID: 37462409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.